| Name | bendazac |
|---|---|
| Synonyms |
bendazolic acid
Bendazacum Bendazaco Acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]- [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid Zildasac (1-Benzyl-1H-indazol-3-yloxy)-acetic acid 1-Benzylindazole-3-oxyacetic acid Versus Bendazacum [INN-Latin] Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]- [(1-Benzyl-3-indazolyl)oxy]acetic Acid Bendazac EINECS 243-569-2 MFCD00866158 Bindazac [[1-(Phenylmethyl)-1H-indazol-3-yl]oxy]acetic Acid 2-(1-benzylindazol-3-yl)oxyacetic acid 2-((1-Benzyl-1H-indazol-3-yl)oxy)acetic acid |
| Description | Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Bendazac is an anti-inflammatory agent endowed with protein antidenaturant properties effective for various inflammatory skin conditions. Bendazac has been shown to be a strong reacting substrate in a chemical oxidizing system, which mimics a physiological pathway of hydroxy radical generation[2]. By using EPR spectroscopy of spin-labelled bovine serum albumin (BSA), Bendazac was shown to prevent the BSA denaturation induced by urea, heat and free radicals produced in the xanthine/xanthine oxidase system[2]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 508.2±35.0 °C at 760 mmHg |
| Melting Point | 161-163ºC |
| Molecular Formula | C16H14N2O3 |
| Molecular Weight | 282.294 |
| Flash Point | 261.1±25.9 °C |
| Exact Mass | 282.100433 |
| PSA | 64.35000 |
| LogP | 3.06 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.630 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933990090 |
|---|
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |